Beck-Peccoz Paolo, Persani Luca, Calebiro Davide, Bonomi Marco, Mannavola Deborah, Campi Irene
Department of Medical Sciences, Endocrine and Metabolic Unit, Fondazione Ospedale Maggiore IRCCS, Padiglione Granelli, Via Francesco Sforza 35, 20122-Milano, Italy.
Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):529-46. doi: 10.1016/j.beem.2006.11.001.
Forty years have elapsed since the first description of a syndrome of resistance in the hypothalamic-pituitary-thyroid axis, i.e., resistance to thyroid hormone action. In the last two decades many other types of resistance have been discovered, including resistance to the action of thyrotropin-releasing hormone (TRH), of thyroid-stimulating hormone (TSH), and of thyroid hormones (THs); the latter can be due not only to thyroid hormone receptor defects but also to alteration in genes encoding TH-specific transporters or components involved in metabolic pathways of THs. Moreover, alteration in genes encoding for second messengers may cause forms of resistance other than those due to receptor mutations, the most important one being that of an inactivating mutation in the G-protein alpha-subunit leading to TSH resistance in the setting of pseudohypoparathyroidism type 1a. Recognition of these rare thyroid disorders is of great importance not only for informed genetic counselling but also for avoiding diagnostic mistakes that may lead to incorrect and potentially dangerous treatments.
自首次描述下丘脑 - 垂体 - 甲状腺轴抵抗综合征,即甲状腺激素作用抵抗以来,已经过去了四十年。在过去二十年中,人们发现了许多其他类型的抵抗,包括对促甲状腺激素释放激素(TRH)、促甲状腺激素(TSH)和甲状腺激素(THs)作用的抵抗;后者不仅可能由于甲状腺激素受体缺陷,还可能由于编码TH特异性转运蛋白或参与TH代谢途径的成分的基因改变。此外,编码第二信使的基因改变可能导致除受体突变引起的抵抗形式之外的其他形式的抵抗,其中最重要的是G蛋白α亚基的失活突变导致1a型假性甲状旁腺功能减退症中的TSH抵抗。认识到这些罕见的甲状腺疾病不仅对于提供充分的遗传咨询非常重要,而且对于避免可能导致不正确和潜在危险治疗的诊断错误也非常重要。